Larvol Delta - ACELYRIN-INC-Announces-Topline-Results-From-Phase-2b3-Study-of-Izokibep-for-the-Treatment-of-Uveitis

izokibep (ABY-035) - ACELYRIN

https://www.globenewswire.com/news-release/2024/12/10/2994971/0/en/ACELYRIN-INC-Announces-Topline-Results-From-Phase-2b-3-Study-of-Izokibep-for-the-Treatment-of-Uveitis.html

Dec 10, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next